Orthovita has received 510(k) clearance from the FDA to market Vitomatrix Bone Graft Substitute as a bone grafting material in certain dental procedures.
Vitomatrix is a resorbable, highly porous synthetic scaffold that utilizes the core proprietary technology from the company's Vitoss Bone Graft Substitute product line.
Vitomatrix is indicated for use in procedures to fill, augment, or reconstruct periodontal or bony defects of the oral and maxillofacial region, according to Orthovita. An estimated 375,000 procedures are performed domestically each year where Vitomatrix can be used, the company said.
Orthovita is evaluating potential commercial partners to distribute the product or license its underlying technology.
Copyright © 2010 DrBicuspid.com
